Ethical considerations for administering alcohol or alcohol cues to treatment-seeking alcoholics in a research setting: Can the benefits to society outweigh the risks to the individual?

Alcoholism: Clinical and Experimental Research

Volumn 33, Issue 9, 2009, Pages 1508-1512

  Enoch, Mary Anne ^a   Johnson, Kenneth ^b   George, David T ^a   Schumann, Gunter ^c   Moss, Howard B ^a   Kranzler, Henry R ^d   Goldman, David ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; CLINICAL RESEARCH; HELP SEEKING BEHAVIOR; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; MEDICAL ETHICS; NOTE; PATIENT SAFETY; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; UNITED STATES;

ALCOHOLISM; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CUES; ETHANOL; ETHICS, RESEARCH; HARM REDUCTION; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; RECOVERY OF FUNCTION; RISK ASSESSMENT; TEMPERANCE;

EID: 69249139572     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2009.00988.x     Document Type: Note

References (23)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association, Washington, DC.
2. Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65 : 135 144.
3. Brandon TH, Lisman SA (2000) Introduction to the special section on empirical underpinnings of the ethics of alcohol administration in research settings. Psychol Addict Behav 14 : 315 318.
4. Brown CG, Stewart SH, Larsen SE (2005) Experiences of harm reduction among women with alcohol use problems. Can J Commun Ment Health 24 : 95 113.
5. Dawson DA, Goldstein RB, Grant BF (2007) Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up. Alcohol Clin Exp Res 31 : 2036 2045.
6. Dolinsky ZS, Babor TF (1997) Ethical, scientific and clinical issues in ethanol administration research involving alcoholics as human subjects. Addiction 92 : 1087 1097.
7. Fein G, Landman B (2005) Treated and treatment-naive alcoholics come from different populations. Alcohol 36 : 19 26.
8. Gelernter G, Gueorguieva R, Kranzler HR, Zhang H, Cramer J, Rosenheck R, Krystal JH, VA Cooperative Study #425 Study Group (2007) Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res 31 : 555 563.
9. George DT, Gilman J, Hersh J, Thorsell A, Herion D, Geyer C, Peng X, Kielbasa W, Rawlings R, Brandt JE, Gehlert DR, Tauscher JT, Hunt SP, Hommer D, Heilig M (2008) Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science 319 : 1536 1539.
10. Kranzler HR, Dolinsky Z, Kaplan RF (1990) Giving ethanol to alcoholics in a research setting: its effect on compliance with disulfiram treatment. Br J Addict 85 : 119 123.
11. Kranzler HR, Gage A (2008) Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials. Am J Addict 17 : 70 76.
12. Marlatt GA, Witkiewitz K (2002) Harm reduction approaches to alcohol use: health promotion, prevention, and treatment. Addict Behav 27 : 867 886.
13. Modell JG, Glaser FB, Mountz JM (1993) The ethics and safety of alcohol administration in the experimental setting to individuals who have chronic, severe alcohol problems. Alcohol Alcohol 28 : 189 197.
14. Moss HB, Chen CM, Yi HY (2007) Subtypes of alcohol dependence in a nationally representative sample. Drug Alcohol Depend 91 : 149 158.
15. National Advisory Council on Alcohol Abuse and Alcoholism - Recommended Council Guidelines on Ethyl Alcohol Administration in Human Experimentation (2005). Available on the National Institute on Alcohol Abuse and Alcoholism website (http://www.niaaa.nih.gov/) under 'About NIAAA - Advisory Council - Research Guidelines and Resources': http://www.niaaa.nih.gov/Resources/ ResearchResources/job22.htm.
16. O'Malley SS, Garbutt JC, Gastfriend DR, Dong Q, Kranzler HR (2007) Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment. J Clin Psychopharmacol 27 : 507 512.
17. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28 : 1546 1552.
18. Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA (2006) The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol 26 : 610 625.
19. Pratt WM, Davidson D (2005) Does participation in an alcohol administration study increase risk for excessive drinking? Alcohol 37 : 135 141.
20. Ramchandani VA, O'Connor S (2006) Studying alcohol elimination using the alcohol clamp method. Alcohol Res Health 29 : 286 290.
21. Ray LA, Hutchison KE (2004) A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 28 : 1789 1795.
22. Tucker JA, Vuchinich RE (2000) Creating a research context for reducing risk and obtaining informed consent in human alcohol studies. Psychol Addict Behav 14 : 319 327.
23. Zimmermann US, Mick I, Vitvitskyi V, Plawecki MH, Mann KF, O'Connor S (2008) Development and pilot validation of computer-assisted self-infusion of ethanol (CASE): a new method to study alcohol self-administration in humans. Alcohol Clin Exp Res 32 : 1321 1328.